Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper

Super-backed company develops COVID treatment

A biotech company backed by AustralianSuper, HESTA, Hostplus and Statewide Super has developed a new preventative treatment shown to reduce COVID-19 levels by up to 96%.

LoginGo Premium

Read more: Ena RespiratoryHESTAHostplusStatewide SuperBrandon CapitalFinancial StandardAustralianSuperChristophe DemaisonChris WilliamsMedical Research Commercialisation FundMH CarnegieSam SiciliaSonya Sawtell-Rickson